4//SEC Filing
SIDRANSKY DAVID 4
Accession 0001493152-23-002246
CIK 0001100397other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 6:19 PM ET
Size
19.3 KB
Accession
0001493152-23-002246
Insider Transaction Report
Form 4
SIDRANSKY DAVID
Director
Transactions
- Award
Stock Option
2023-01-19+2,342→ 2,342 totalExercise: $55.23Exp: 2031-06-09→ Common Stock (2,342 underlying) - Award
Stock Option
2023-01-19+2,342→ 2,342 totalExercise: $8.70Exp: 2032-06-12→ Common Stock (2,342 underlying) - Award
Common Stock
2023-01-19+46→ 46 total(indirect: Held by Reporting Person's Son)
Holdings
- 93
Common Stock
- 17
Stock Option
Exercise: $16128.00Exp: 2025-05-27→ Common Stock (17 underlying) - 25
Stock Option
Exercise: $9252.00Exp: 2026-11-03→ Common Stock (25 underlying) - 25
Stock Option
Exercise: $3828.00Exp: 2027-11-01→ Common Stock (25 underlying) - 25
Stock Option
Exercise: $648.00Exp: 2028-11-04→ Common Stock (25 underlying) - 125
Stock Option
Exercise: $24.80Exp: 2029-10-23→ Common Stock (125 underlying) - 163
Stock Option
Exercise: $52.80Exp: 2030-05-03→ Common Stock (163 underlying) - 42
Stock Option
Exercise: $15372.00Exp: 2025-11-04→ Common Stock (42 underlying)
Footnotes (6)
- [F1]Received in exchange for 250 shares of the common stock of Ayala Pharmaceuticals, Inc. ("Old Ayala") in the merger of Old Ayala into the Issuer (the "Merger"). On the day prior to the effective date of the Merger, the closing price of Old Ayala's common stock was $0.53 per share, and the closing price of the Issuer's common stock was $2.95 per share.
- [F2]This option is fully vested and exercisable.
- [F3]Received in the Merger in exchange for an employee stock option to acquire 12,500 shares of the common stock of Old Ayala for $10.35 per share.
- [F4]This option vests and becomes exercisable on the earlier of (i) June 13, 2023 or (ii) one day prior to the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer through such vesting date.
- [F5]Received in the Merger in exchange for an employee stock option to acquire 12,500 shares of the common stock of Old Ayala for $1.63 per share.
- [F6]Two-thirds of this award is currently vested and the remaining one-third will be vested on May 4, 2023.
Documents
Issuer
Ayala Pharmaceuticals, Inc.
CIK 0001100397
Entity typeother
Related Parties
1- filerCIK 0001277161
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 6:19 PM ET
- Size
- 19.3 KB